Direct evidence from intraneural recordings for increased central sympathetic outflow in patients with heart failure

W. N. Leimbach, B. G. Wallin, R. G. Victor, P. E. Aylward, G. Sundlöf, A. L. Mark

Research output: Contribution to journalArticle

635 Citations (Scopus)

Abstract

Patients with heart failure have increased vascular resistance and evidence for increased neurohumoral drive. High levels of circulating norepinephrine are found in patients with heart failure, but it is not known whether they reflect increased sympathetic neural activity or result from altered synthesis, release, or metabolism of norepinephrine. We used microneurography (peroneal nerve) to directly record sympathetic nerve activity to muscle (mSNA) and also measured plasma norepinephrine levels in patients with heart failure and in normal control subjects. Our goal was to determine whether sympathetic nerve activity is increased in patients with heart failure and whether plasma norepinephrine levels correlate with levels of mSNA in heart failure. Resting muscle sympathetic nerve activity in 16 patients with moderate to severe heart failure (54 ± 5 bursts/min, mean ± SE) was significantly higher (p < .01) than the levels of activity in either nine age-matched normal control subjects (25 ± 4 bursts/min) or 19 'young' normal control subjects (24 ± 2 bursts/min). We found a significant correlation between plasma norepinephrine levels and mSNA (r = .73, p < .05). Neither mSNA nor plasma norepinephrine levels correlated with total systemic vascular resistance, cardiac index, left ventricular ejection fraction, or heart rate. However, both mSNA and plasma norepinephrine levels showed significant positive correlations (p < .05) with left ventricular filling pressures (r = .80, mSNA vs filling pressures; r = .82, norepinephrine levels vs filling pressures) and mean right atrial pressure. The results of the study provide the first direct evidence of increased central sympathetic nerve outflow in patients with heart failure and the first direct evidence that plasma norepinephrine levels show a reasonable correlation with sympathetic nerve activity to muscle in these patients. Furthermore, the data suggest that preload is an important determinant of SNA in these patients.

LanguageEnglish
Pages913-919
Number of pages7
JournalCirculation
Volume73
Issue number5
DOIs
Publication statusPublished - 1 Jan 1986
Externally publishedYes

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine
  • Physiology (medical)

Cite this

Leimbach, W. N., Wallin, B. G., Victor, R. G., Aylward, P. E., Sundlöf, G., & Mark, A. L. (1986). Direct evidence from intraneural recordings for increased central sympathetic outflow in patients with heart failure. Circulation, 73(5), 913-919. https://doi.org/10.1161/01.CIR.73.5.913
Leimbach, W. N. ; Wallin, B. G. ; Victor, R. G. ; Aylward, P. E. ; Sundlöf, G. ; Mark, A. L. / Direct evidence from intraneural recordings for increased central sympathetic outflow in patients with heart failure. In: Circulation. 1986 ; Vol. 73, No. 5. pp. 913-919.
@article{fdc0540a8d93461199046db700509382,
title = "Direct evidence from intraneural recordings for increased central sympathetic outflow in patients with heart failure",
abstract = "Patients with heart failure have increased vascular resistance and evidence for increased neurohumoral drive. High levels of circulating norepinephrine are found in patients with heart failure, but it is not known whether they reflect increased sympathetic neural activity or result from altered synthesis, release, or metabolism of norepinephrine. We used microneurography (peroneal nerve) to directly record sympathetic nerve activity to muscle (mSNA) and also measured plasma norepinephrine levels in patients with heart failure and in normal control subjects. Our goal was to determine whether sympathetic nerve activity is increased in patients with heart failure and whether plasma norepinephrine levels correlate with levels of mSNA in heart failure. Resting muscle sympathetic nerve activity in 16 patients with moderate to severe heart failure (54 ± 5 bursts/min, mean ± SE) was significantly higher (p < .01) than the levels of activity in either nine age-matched normal control subjects (25 ± 4 bursts/min) or 19 'young' normal control subjects (24 ± 2 bursts/min). We found a significant correlation between plasma norepinephrine levels and mSNA (r = .73, p < .05). Neither mSNA nor plasma norepinephrine levels correlated with total systemic vascular resistance, cardiac index, left ventricular ejection fraction, or heart rate. However, both mSNA and plasma norepinephrine levels showed significant positive correlations (p < .05) with left ventricular filling pressures (r = .80, mSNA vs filling pressures; r = .82, norepinephrine levels vs filling pressures) and mean right atrial pressure. The results of the study provide the first direct evidence of increased central sympathetic nerve outflow in patients with heart failure and the first direct evidence that plasma norepinephrine levels show a reasonable correlation with sympathetic nerve activity to muscle in these patients. Furthermore, the data suggest that preload is an important determinant of SNA in these patients.",
author = "Leimbach, {W. N.} and Wallin, {B. G.} and Victor, {R. G.} and Aylward, {P. E.} and G. Sundl{\"o}f and Mark, {A. L.}",
year = "1986",
month = "1",
day = "1",
doi = "10.1161/01.CIR.73.5.913",
language = "English",
volume = "73",
pages = "913--919",
journal = "Circulation",
issn = "0009-7322",
publisher = "Lippincott Williams and Wilkins",
number = "5",

}

Leimbach, WN, Wallin, BG, Victor, RG, Aylward, PE, Sundlöf, G & Mark, AL 1986, 'Direct evidence from intraneural recordings for increased central sympathetic outflow in patients with heart failure', Circulation, vol. 73, no. 5, pp. 913-919. https://doi.org/10.1161/01.CIR.73.5.913

Direct evidence from intraneural recordings for increased central sympathetic outflow in patients with heart failure. / Leimbach, W. N.; Wallin, B. G.; Victor, R. G.; Aylward, P. E.; Sundlöf, G.; Mark, A. L.

In: Circulation, Vol. 73, No. 5, 01.01.1986, p. 913-919.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Direct evidence from intraneural recordings for increased central sympathetic outflow in patients with heart failure

AU - Leimbach, W. N.

AU - Wallin, B. G.

AU - Victor, R. G.

AU - Aylward, P. E.

AU - Sundlöf, G.

AU - Mark, A. L.

PY - 1986/1/1

Y1 - 1986/1/1

N2 - Patients with heart failure have increased vascular resistance and evidence for increased neurohumoral drive. High levels of circulating norepinephrine are found in patients with heart failure, but it is not known whether they reflect increased sympathetic neural activity or result from altered synthesis, release, or metabolism of norepinephrine. We used microneurography (peroneal nerve) to directly record sympathetic nerve activity to muscle (mSNA) and also measured plasma norepinephrine levels in patients with heart failure and in normal control subjects. Our goal was to determine whether sympathetic nerve activity is increased in patients with heart failure and whether plasma norepinephrine levels correlate with levels of mSNA in heart failure. Resting muscle sympathetic nerve activity in 16 patients with moderate to severe heart failure (54 ± 5 bursts/min, mean ± SE) was significantly higher (p < .01) than the levels of activity in either nine age-matched normal control subjects (25 ± 4 bursts/min) or 19 'young' normal control subjects (24 ± 2 bursts/min). We found a significant correlation between plasma norepinephrine levels and mSNA (r = .73, p < .05). Neither mSNA nor plasma norepinephrine levels correlated with total systemic vascular resistance, cardiac index, left ventricular ejection fraction, or heart rate. However, both mSNA and plasma norepinephrine levels showed significant positive correlations (p < .05) with left ventricular filling pressures (r = .80, mSNA vs filling pressures; r = .82, norepinephrine levels vs filling pressures) and mean right atrial pressure. The results of the study provide the first direct evidence of increased central sympathetic nerve outflow in patients with heart failure and the first direct evidence that plasma norepinephrine levels show a reasonable correlation with sympathetic nerve activity to muscle in these patients. Furthermore, the data suggest that preload is an important determinant of SNA in these patients.

AB - Patients with heart failure have increased vascular resistance and evidence for increased neurohumoral drive. High levels of circulating norepinephrine are found in patients with heart failure, but it is not known whether they reflect increased sympathetic neural activity or result from altered synthesis, release, or metabolism of norepinephrine. We used microneurography (peroneal nerve) to directly record sympathetic nerve activity to muscle (mSNA) and also measured plasma norepinephrine levels in patients with heart failure and in normal control subjects. Our goal was to determine whether sympathetic nerve activity is increased in patients with heart failure and whether plasma norepinephrine levels correlate with levels of mSNA in heart failure. Resting muscle sympathetic nerve activity in 16 patients with moderate to severe heart failure (54 ± 5 bursts/min, mean ± SE) was significantly higher (p < .01) than the levels of activity in either nine age-matched normal control subjects (25 ± 4 bursts/min) or 19 'young' normal control subjects (24 ± 2 bursts/min). We found a significant correlation between plasma norepinephrine levels and mSNA (r = .73, p < .05). Neither mSNA nor plasma norepinephrine levels correlated with total systemic vascular resistance, cardiac index, left ventricular ejection fraction, or heart rate. However, both mSNA and plasma norepinephrine levels showed significant positive correlations (p < .05) with left ventricular filling pressures (r = .80, mSNA vs filling pressures; r = .82, norepinephrine levels vs filling pressures) and mean right atrial pressure. The results of the study provide the first direct evidence of increased central sympathetic nerve outflow in patients with heart failure and the first direct evidence that plasma norepinephrine levels show a reasonable correlation with sympathetic nerve activity to muscle in these patients. Furthermore, the data suggest that preload is an important determinant of SNA in these patients.

UR - http://www.scopus.com/inward/record.url?scp=0022591615&partnerID=8YFLogxK

U2 - 10.1161/01.CIR.73.5.913

DO - 10.1161/01.CIR.73.5.913

M3 - Article

VL - 73

SP - 913

EP - 919

JO - Circulation

T2 - Circulation

JF - Circulation

SN - 0009-7322

IS - 5

ER -